Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, forecasts that the Indian hepatitis B virus drug market will grow ten-fold by 2012, from $1.7 million in 2007 to $17 million in 2012.
120183
India's hepatitis B virus drug market will grow ten-fold by 2012
75485
BSE Sensex seen ranged early ahead of expiry
164603
Price to pay for health
75818
Roche makes $230 million bet on hepatitis drug developer Anadys
102235
Medicine prices have yet to go down --
123034
Animal trials for H1N1 vaccine begin in India
114054
Market share of cannabis herb increasing across Europe
11690
Indian healthcare sector to create a demand for 34 million smart cards
154106
National treatment Network taps growing addiction treatment market
120360
Sales of antiretroviral agents for HIV will decline slightly over the next decade
36309
IPL's brand value doubles to $4.1 billion
121461
Mathematical models predict success of movies at box office
75625
Genzyme faces production delays for key drugs
157370
Number of doctors increasing
79082
Pharmaceutical industry faces collapse
7408
Pfizer to explore strategic alternatives for its Animal Health and Nutrition businesses
138224
Time to develop national voluntary blood donation programme